Drug profile · INN
siponimod fumaric acid
MAYZENT
siponimod fumaric acid (MAYZENT) is a sphingosine 1-phosphate receptor edg-1 agonist.
PMDA: approved
Patents linked 0
Pipeline programs 3
News articles 0
Drug details — siponimod fumaric acid
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 3
- Data quality
- 0.78
Quick answer
siponimod fumaric acid (MAYZENT) is a sphingosine 1-phosphate receptor edg-1 agonist.
Key facts
INN siponimod fumaric acid
Brand MAYZENT
Mechanism Sphingosine 1-phosphate receptor Edg-1 agonist
Target Sphingosine 1-phosphate receptor 1
Mechanism of action
Sphingosine 1-phosphate receptor Edg-1 agonist
Primary target: Sphingosine 1-phosphate receptor 1
Approval history
| Authority | Status | Date |
|---|---|---|
| PMDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is siponimod fumaric acid?
siponimod fumaric acid (MAYZENT) is a sphingosine 1-phosphate receptor edg-1 agonist.
What is the brand name for siponimod fumaric acid?
MAYZENT is a marketed brand name for siponimod fumaric acid. Check FDA Drugs@FDA for the current US label holder and prescribing information.